Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Catalyst Pharmaceuticals Revenue 2010-2025 | CPRX

Catalyst Pharmaceuticals revenue from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
Catalyst Pharmaceuticals Annual Revenue
(Millions of US $)
2024 $492
2023 $398
2022 $214
2021 $141
2020 $119
2019 $102
2018 $1
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Catalyst Pharmaceuticals Quarterly Revenue
(Millions of US $)
2025-03-31 $141
2024-12-31 $142
2024-09-30 $129
2024-06-30 $123
2024-03-31 $99
2023-12-31 $111
2023-09-30 $103
2023-06-30 $100
2023-03-31 $85
2022-12-31 $61
2022-09-30 $57
2022-06-30 $53
2022-03-31 $43
2021-12-31 $38
2021-09-30 $36
2021-06-30 $36
2021-03-31 $30
2020-12-31 $31
2020-09-30 $29
2020-06-30 $30
2020-03-31 $29
2019-12-31 $30
2019-09-30 $31
2019-06-30 $29
2019-03-31 $12
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.698B $0.492B
Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights to Firdapse (for treating LEMS) from BioMarin Pharmaceutical Inc. for its development and commercialization in the U.S. Firdapse is currently approved in the European Union and in the U.S. for treating of LEMS in adults. The company also plans to file a supplemental new drug application for Firdapse to treat pediatric patients with LEMS.?The company is also strengthening the commercial portfolio of Firdapse. It has already received multiple patents that cover the treatment of all amifampridine metabolizer types within the LEMS patient population.?Apart from Firdapse, the company is working on a generic version of Lundbeck's Sabril, CPP-109, for the treatment of infantile spasms and complex partial seizures.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.744B 31.79
Zoetis (ZTS) United States $70.049B 26.14
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $43.381B 22.23
BeOne Medicines - (ONC) Cayman Islands $28.223B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.505B 0.00
Merck (MKKGY) Germany $16.394B 12.01
Summit Therapeutics (SMMT) United States $15.143B 0.00
Shionogi (SGIOY) Japan $14.700B 14.73
United Therapeutics (UTHR) United States $12.918B 11.43
Neurocrine Biosciences (NBIX) United States $12.450B 42.64
Orion OYJ (ORINY) Finland $10.594B 28.65
IPSEN (IPSEY) France $9.607B 0.00
Corcept Therapeutics (CORT) United States $7.877B 64.03
Stevanato Group S.p.A (STVN) Italy $7.099B 43.41
Madrigal Pharmaceuticals (MDGL) United States $6.283B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.996B 0.00
Grifols, S.A (GRFS) Spain $5.755B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.103B 0.00
Hypermarcas (HYPMY) Brazil $2.907B 19.12
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.481B 13.41
BioCryst Pharmaceuticals (BCRX) United States $2.074B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.044B 0.00
Indivior (INDV) United States $1.923B 8.16
Centessa Pharmaceuticals (CNTA) United Kingdom $1.736B 0.00
ARS Pharmaceuticals (SPRY) United States $1.627B 0.00
Endo (NDOI) United States $1.595B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Ocular Therapeutix (OCUL) United States $1.333B 0.00
Guardian Pharmacy Services (GRDN) United States $1.286B 0.00
Dyne Therapeutics (DYN) United States $1.155B 0.00
Harrow (HROW) United States $1.137B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.058B 21.16
Enliven Therapeutics (ELVN) United States $0.996B 0.00
Verve Therapeutics (VERV) United States $0.990B 0.00
Collegium Pharmaceutical (COLL) United States $0.960B 5.18
Akebia Therapeutics (AKBA) United States $0.956B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.923B 0.00
Ardelyx (ARDX) United States $0.869B 0.00
Elite Pharmaceuticals (ELTP) United States $0.801B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Cronos Group (CRON) Canada $0.721B 0.00
Xencor (XNCR) United States $0.599B 0.00
KalVista Pharmaceuticals (KALV) United States $0.593B 0.00
Altimmune (ALT) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.565B 12.29
Regulus Therapeutics (RGLS) United States $0.564B 0.00
Relay Therapeutics (RLAY) United States $0.554B 0.00
Bioventus (BVS) United States $0.536B 13.58
Theravance Biopharma (TBPH) United States $0.529B 0.00
Liminatus Pharma (LIMN) United States $0.520B 0.00
AleAnna (ANNA) United States $0.504B 0.00
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.442B 9.24
Tourmaline Bio (TRML) United States $0.437B 0.00
Organogenesis (ORGO) United States $0.424B 0.00
Oruka Therapeutics (ORKA) United States $0.408B 0.00
Savara (SVRA) United States $0.373B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.337B 9.10
Aquestive Therapeutics (AQST) United States $0.327B 0.00
Heron Therapeutics (HRTX) United States $0.322B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.27
Tonix Pharmaceuticals Holding (TNXP) United States $0.241B 0.00
Nanobiotix S.A (NBTX) France $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.206B 0.00
MediWound (MDWD) Israel $0.205B 0.00
OmniAb (OABI) United States $0.197B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
ProKidney (PROK) United States $0.177B 0.00
4D Molecular Therapeutics (FDMT) United States $0.175B 0.00
Galectin Therapeutics (GALT) United States $0.157B 0.00
Larimar Therapeutics (LRMR) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.151B 0.00
Journey Medical (DERM) United States $0.149B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Avita Medical (RCEL) United States $0.136B 0.00
Achieve Life Sciences (ACHV) Canada $0.133B 0.00
Lyell Immunopharma (LYEL) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.111B 18.32
Protara Therapeutics (TARA) United States $0.111B 0.00
Korro Bio (KRRO) United States $0.110B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Unicycive Therapeutics (UNCY) United States $0.090B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Wellgistics Health (WGRX) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.059B 43.67
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.16
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
GlycoMimetics (CBIO) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00